Product containing rimegepant (medicinal product)
RxNorm 2282307
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2282307 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing rimegepant (medicinal product).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing rimegepant (medicinal product)
(Atom ID: 12421875)
INPrescribable
Ingredient (IN):
Rimegepant
(Atom ID: 12776580)
PTPrescribable
Designated preferred name (PT):
Rimegepant
(Atom ID: 12421920)
FNPrescribable
Full form of descriptor (FN):
Rimegepant (substance)
(Atom ID: 12421921)
PTPrescribable
Designated preferred name (PT):
Rimegepant-containing product
(Atom ID: 12421924)
Patient Education
Rimegepant
Rimegepant is used to prevent and treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light). Rimegepant is in a class of medications called calcitonin gene-related peptide receptor antagonists. It works by blocking the action of a certain natural substance in the body that causes migraine headaches.
[Learn More]
* Please review the disclaimer below.